Medicine and Dentistry
Age
11%
Analysis
14%
Association
16%
Body Mass Index
7%
Cancer
6%
Cancer Registry
11%
Cancer Risk
13%
Carboplatin
7%
Cells
19%
Chemoradiotherapy
9%
Chemotherapy
24%
Cisplatin
17%
Combination Therapy
25%
Computed Tomography
6%
Diagnosis
9%
Diseases
32%
Drug Megadose
6%
Follow up
6%
Gene
14%
Genome Wide Association Study
10%
Head
16%
Head and Neck Cancer
8%
Immune Checkpoint Inhibitor
7%
Inpatient
13%
Low Drug Dose
27%
Lung
15%
Lung Cancer
71%
Malignant Neoplasm
21%
Mendelian Randomization Analysis
7%
Metastatic Carcinoma
12%
Neck
20%
Neoplasm
32%
Neuroendocrine Tumor
10%
Non Small Cell Lung Cancer
14%
Odds Ratio
9%
Overall Survival
17%
Paclitaxel
8%
Patient
100%
Primary Tumor
8%
Progression Free Survival
7%
Radiation
14%
Radiation Therapy
22%
Single Nucleotide Polymorphism
10%
Smoking
21%
Squamous Cell Carcinoma
16%
Surgery
10%
Survival
22%
Therapeutic Procedure
36%
Tissues
9%
Toxicity
16%
Biochemistry, Genetics and Molecular Biology
Age
5%
Association
19%
Body Mass
6%
Cancer Incidence
8%
Cancer Mortality
5%
Cancer Registry
6%
Development
7%
Electric Potential
9%
Expression Quantitative Trait Loci
5%
Gene Interaction
8%
Genetics
11%
Genome-Wide Association Study
12%
Major Histocompatibility Complex
5%
Mutation
12%
Nested Gene
30%
Sample
9%
Screening
9%
Single Nucleotide Polymorphism
6%
Single-Nucleotide Polymorphism
12%
Smoking
22%
Solid
6%
Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Camptothecin
5%
Carboplatin
6%
Carfilzomib
6%
Diseases
9%
Irinotecan
10%
Lung Cancer
8%
Malignant Neoplasm
12%
Neoplasm
13%
Neutropenia
6%
Non Small Cell Lung Cancer
5%
Overall Survival
8%
Paclitaxel
7%
Pharmacokinetics
5%
Radiation
14%
Small Cell Lung Cancer
6%
Solid Malignant Neoplasm
5%
Squamous Cell Carcinoma
7%
Survival
6%
Toxicity
21%
